Welcome to
Ondek Pty Ltd

Biological delivery systems

Ondek Pty Ltd is an Australian biotechnology company developing a novel drug delivery platform, known as the Helicobacter pylori Platform Technology (HPPT).

The platform utilizes the unique characteristics of Helicobacter pylori bacterium to deliver a diverse range of therapeutics to the patient, including immune modulators, biopharmaceuticals or other drugs, and vaccines.

Ondek was founded by Nobel Laureate Professor Barry Marshall, a world authority and co-discoverer of the Helicobacter pylori organism and co-recipient of the 2005 Nobel Prize for Medicine and Physiology.

Welcome to
Ondek Pty Ltd

Biological delivery systems

Ondek Pty Ltd is an Australian biotechnology company developing a novel drug delivery platform, known as the Helicobacter pylori Platform Technology (HPPT).

The platform utilizes the unique characteristics of Helicobacter pylori bacterium to deliver a diverse range of therapeutics to the patient, including immune modulators, biopharmaceuticals or other drugs, and vaccines.

Ondek was founded by Nobel Laureate Professor Barry Marshall, a world authority and co-discoverer of the Helicobacter pylori organism and co-recipient of the 2005 Nobel Prize for Medicine and Physiology.

Welcome to Ondek Pty Ltd

Welcome to Ondek Pty Ltd

Biological delivery systems

Biological delivery systems

Ondek Pty Ltd is an Australian biotechnology company developing a novel drug delivery platform, known as the Helicobacter pylori Platform Technology (HPPT).

The platform utilizes the unique characteristics of Helicobacter pylori bacterium to deliver a diverse range of therapeutics to the patient, including immune modulators, biopharmaceuticals or other drugs, and vaccines.

Ondek was founded by Nobel Laureate Professor Barry Marshall, a world authority and co-discoverer of the Helicobacter pylori organism and co-recipient of the 2005 Nobel Prize for Medicine and Physiology.